Fig. 1: Swimmers plot of CNS PFS, OS, response and neurological death from Sacituzumab Govitecan start according to stable / Active / LMD. | npj Breast Cancer

Fig. 1: Swimmers plot of CNS PFS, OS, response and neurological death from Sacituzumab Govitecan start according to stable / Active / LMD.

From: Real-World outcomes with sacituzumab govitecan among breast cancer patients with central nervous system metastases

Fig. 1

Swimmers plot illustrating Central Nervous system progression free survival (CNS-PFS, colored line) and overall survival (OS, gray line), occurrence of extra-CNS progression and death in metastatic breast cancer patients with CNS metastases treated with sacituzumab govitecan. LMD: leptomeningeal disease.

Back to article page